... which decided not to participate in this extraction, the extract cohort available for collection was 7,477 practices. Of the extract cohort, data for 7,300 practices were collected, representing 97.6 per cent coverage of cohort practices. The data shows that in September 2016 426,000 patients had a record of dementia diagnosis on their clinical record.
(Edited publisher abstract)
Provides key data on recorded dementia diagnoses. Recorded dementia prevalence at 30 September 2016 was 0.771 per cent (1 person in 130). When considered alongside monthly data collected in 2014/15, this indicates a progressive increase in recorded prevalence from March 2015 (0.738) to September 2016 (0.771). After adjustments to remove spurious, ‘non-GP’ practices, shared practices and practices which decided not to participate in this extraction, the extract cohort available for collection was 7,477 practices. Of the extract cohort, data for 7,300 practices were collected, representing 97.6 per cent coverage of cohort practices. The data shows that in September 2016 426,000 patients had a record of dementia diagnosis on their clinical record.
(Edited publisher abstract)
Mersey Care provides specialist assessment, diagnosis and support for people with dementia and their families across Liverpool, including a specialist service for people with young onset dementia. In this video Mersey Care team members explain how the needs of people with young onset dementia are different and how the service responds to these. Service users also talk about the importance
(Publisher abstract)
Mersey Care provides specialist assessment, diagnosis and support for people with dementia and their families across Liverpool, including a specialist service for people with young onset dementia. In this video Mersey Care team members explain how the needs of people with young onset dementia are different and how the service responds to these. Service users also talk about the importance of such a service.
(Publisher abstract)
GREAT BRITAIN. Department of Health and Social Care
Publisher:
Great Britain. Department of Health and Social Care
Publication year:
2021
Place of publication:
London
Health, social care and other professionals may need to visit residents within care homes to provide services. This guidance sets out the testing policy for these ‘visiting professionals’. Many visiting professionals work in a variety of different settings per day, including care homes. Given the substantial risks to care home residents if COVID-19 is introduced to the home, it is essential that professionals and all staff are tested regularly before visiting care homes to reduce the risk of transmission across different settings and to help keep residents and staff safe. The guidance covers: NHS professionals visiting care homes who are part of regular staff testing; testing for CQC inspectors visiting care homes; professionals not regularly tested through NHS or CQC staff testing; 90-day window; and void or invalid results. [Last updated: 7 July 2021]
(Edited publisher abstract)
Health, social care and other professionals may need to visit residents within care homes to provide services. This guidance sets out the testing policy for these ‘visiting professionals’. Many visiting professionals work in a variety of different settings per day, including care homes. Given the substantial risks to care home residents if COVID-19 is introduced to the home, it is essential that professionals and all staff are tested regularly before visiting care homes to reduce the risk of transmission across different settings and to help keep residents and staff safe. The guidance covers: NHS professionals visiting care homes who are part of regular staff testing; testing for CQC inspectors visiting care homes; professionals not regularly tested through NHS or CQC staff testing; 90-day window; and void or invalid results. [Last updated: 7 July 2021]
(Edited publisher abstract)
Subject terms:
care homes, Covid-19, infection control, diagnosis;
GREAT BRITAIN. Department of Health and Social Care
Publisher:
Great Britain. Department of Health and Social Care
Publication year:
2021
Place of publication:
London
This guidance is for all adult social care services where on-site testing is conducted using rapid lateral flow tests. provide guidance on how to prepare and manage on-site lateral flow testing. On-site testing can reduce the risk of coronavirus (COVID-19) but it does not completely remove the risk of infection. All other IPC measures must continue to be followed. It covers: rapid LFT technology, training and safety; how to use the handheld scanner; preparing the testing area; checking in the person being tested; sample collection; sample analysis; results analysis; process and record results; and results guidance. [Last updated: 5 July 2021]
(Edited publisher abstract)
This guidance is for all adult social care services where on-site testing is conducted using rapid lateral flow tests. provide guidance on how to prepare and manage on-site lateral flow testing. On-site testing can reduce the risk of coronavirus (COVID-19) but it does not completely remove the risk of infection. All other IPC measures must continue to be followed. It covers: rapid LFT technology, training and safety; how to use the handheld scanner; preparing the testing area; checking in the person being tested; sample collection; sample analysis; results analysis; process and record results; and results guidance. [Last updated: 5 July 2021]
(Edited publisher abstract)
Subject terms:
adult social care, Covid-19, diagnosis, infection control;
Analyses of trends in GP diagnosed depression in the adult population in England between 23 March and 31 August 2020, compared to pre-pandemic levels. Main points include: there was a 29.7% decrease in all diagnoses by GPs in England during the pandemic period covered in this report (23 March to 31 August 2020) compared with the same period in 2019; during the same period, the number of depression diagnoses fell from 1,131,804 in 2019 to 863,578, a decrease of 23.7%; there was a bigger drop for men (27.4% decrease) than for women (21.4% decrease); those aged 45 to 54 years are the age group with the largest fall in the number of depression diagnoses (30.1% decrease); in contrast, depression diagnoses as percentage of all diagnoses rose by 1.3 percentage points to 15.6%, when compared with the corresponding 2019 period; depression diagnoses as a percentage of all diagnoses increased slightly among people aged 45 years and over, compared to the corresponding period in 2019; among those aged 25 to 34 years there was a drop of 2.3 percentage points; the Chinese ethnic group saw a 4.0 percentage point increase in depression diagnoses as a percentage of all diagnoses, the largest percentage point change of any ethnic group; as a percentage of all diagnoses, depression diagnoses increased most among people living in the second most deprived areas (1.5 percentage points); the increase was lowest (0.9 percentage points) among people living in the least deprived areas.
(Edited publisher abstract)
Analyses of trends in GP diagnosed depression in the adult population in England between 23 March and 31 August 2020, compared to pre-pandemic levels. Main points include: there was a 29.7% decrease in all diagnoses by GPs in England during the pandemic period covered in this report (23 March to 31 August 2020) compared with the same period in 2019; during the same period, the number of depression diagnoses fell from 1,131,804 in 2019 to 863,578, a decrease of 23.7%; there was a bigger drop for men (27.4% decrease) than for women (21.4% decrease); those aged 45 to 54 years are the age group with the largest fall in the number of depression diagnoses (30.1% decrease); in contrast, depression diagnoses as percentage of all diagnoses rose by 1.3 percentage points to 15.6%, when compared with the corresponding 2019 period; depression diagnoses as a percentage of all diagnoses increased slightly among people aged 45 years and over, compared to the corresponding period in 2019; among those aged 25 to 34 years there was a drop of 2.3 percentage points; the Chinese ethnic group saw a 4.0 percentage point increase in depression diagnoses as a percentage of all diagnoses, the largest percentage point change of any ethnic group; as a percentage of all diagnoses, depression diagnoses increased most among people living in the second most deprived areas (1.5 percentage points); the increase was lowest (0.9 percentage points) among people living in the least deprived areas.
(Edited publisher abstract)
GREAT BRITAIN. Department of Health and Social Care
Publisher:
Great Britain. Department of Health and Social Care
Publication year:
2021
Place of publication:
London
This guidance explains what care homes should do in the event of a suspected or confirmed Covid-19 outbreak. Care homes should follow a regular staff testing regime of weekly PCR testing and twice weekly lateral flow testing. An outbreak is defined as two or more clinically suspected or confirmed positives (rapid lateral flow or PCR) among residents or staff detected in the same 14-day period. However, one positive test result may be the first sign of an outbreak, so care homes should contact your local health protection team (HPT) for advice in this instance. Note this guidance was updated to reflect: changes to self-isolation guidance came into effect on 16 August 2021 and Changes to policy when there is one case of COVID-19 in a care home. Change to LFT testing frequency. Change to policy when there are 2 or more cases of COVID-19 in a care home. Change to ending outbreak restrictions, when they can be lifted and ongoing testing after this period, on 29 September 2021.
[Published: 24 March 2021; Last updated: 29 September 2021]
(Edited publisher abstract)
This guidance explains what care homes should do in the event of a suspected or confirmed Covid-19 outbreak. Care homes should follow a regular staff testing regime of weekly PCR testing and twice weekly lateral flow testing. An outbreak is defined as two or more clinically suspected or confirmed positives (rapid lateral flow or PCR) among residents or staff detected in the same 14-day period. However, one positive test result may be the first sign of an outbreak, so care homes should contact your local health protection team (HPT) for advice in this instance. Note this guidance was updated to reflect: changes to self-isolation guidance came into effect on 16 August 2021 and Changes to policy when there is one case of COVID-19 in a care home. Change to LFT testing frequency. Change to policy when there are 2 or more cases of COVID-19 in a care home. Change to ending outbreak restrictions, when they can be lifted and ongoing testing after this period, on 29 September 2021.
[Published: 24 March 2021; Last updated: 29 September 2021]
(Edited publisher abstract)
Subject terms:
care homes, Covid-19, infection control, diagnosis;
GREAT BRITAIN. Department of Health and Social Care
Publisher:
Great Britain. Department of Health and Social Care
Publication year:
2020
Pagination:
42
Place of publication:
London
Edition:
Version 1.7
This document provides clinical guidance for the testing of visitors for SARS-CoV-2 (the virus that causes COVID-19) using lateral flow technology on entry to residential care homes. A visitor is defined as any relative or friend wishing to visit a resident or any occasional visiting professional who is not a healthcare professional (e.g., a hairdresser). There has been a clear ministerial steer that for visitors to be allowed into care homes as part of overall approach to promoting wellbeing amongst care homes residents. Lateral Flow Antigen testing involves the processing of human nasal swabs, throat swabs, or sputum samples with a Lateral Flow Device (LFD). The device detects a protein (antigen) produced by the virus at its most infectious stage. The document provides advice in relation to site set-up; testing process; supply and equipment management; and data management.
(Edited publisher abstract)
This document provides clinical guidance for the testing of visitors for SARS-CoV-2 (the virus that causes COVID-19) using lateral flow technology on entry to residential care homes. A visitor is defined as any relative or friend wishing to visit a resident or any occasional visiting professional who is not a healthcare professional (e.g., a hairdresser). There has been a clear ministerial steer that for visitors to be allowed into care homes as part of overall approach to promoting wellbeing amongst care homes residents. Lateral Flow Antigen testing involves the processing of human nasal swabs, throat swabs, or sputum samples with a Lateral Flow Device (LFD). The device detects a protein (antigen) produced by the virus at its most infectious stage. The document provides advice in relation to site set-up; testing process; supply and equipment management; and data management.
(Edited publisher abstract)
Subject terms:
care homes, Covid-19, infection control, diagnosis;
GREAT BRITAIN. Department of Health and Social Care
Publisher:
Great Britain. Department of Health and Social Care
Publication year:
2020
Place of publication:
London
A summary of published research papers on lateral flow device (LFD) efficacy and preliminary findings from the evaluation of the Department of Health and Social Care (DHSC) care home visitor testing pilot November 2020. The summary follows the release of visitor testing guidance that supports friends and relatives to visit care home residents and provides clarity on the available evidence to support safe visiting as part of our overall approach to promote the health and wellbeing of care home residents. Friends and relatives tested immediately before their visit can demonstrate they are likely to be free of risk of transmitting COVID-19 by having an LFD negative result. Testing must be done directly before the visit takes place and must be undertaken in combination with other infection prevention and control measures.
(Edited publisher abstract)
A summary of published research papers on lateral flow device (LFD) efficacy and preliminary findings from the evaluation of the Department of Health and Social Care (DHSC) care home visitor testing pilot November 2020. The summary follows the release of visitor testing guidance that supports friends and relatives to visit care home residents and provides clarity on the available evidence to support safe visiting as part of our overall approach to promote the health and wellbeing of care home residents. Friends and relatives tested immediately before their visit can demonstrate they are likely to be free of risk of transmitting COVID-19 by having an LFD negative result. Testing must be done directly before the visit takes place and must be undertaken in combination with other infection prevention and control measures.
(Edited publisher abstract)
Subject terms:
Covid-19, infection control, diagnosis, care homes;
International Journal of Geriatric Psychiatry, 33(8), 2018, pp.1090-1097.
Publisher:
Wiley
Objective: In England, two primary care incentive schemes were introduced to increase dementia diagnosis rates to two‐thirds of expected levels. This study assesses the effectiveness of these schemes. Methods: The study used a difference‐in‐differences framework to analyse the individual and collective impacts of the incentive schemes: (1) Directed Enhanced Service 18 (DES18: facilitating timely diagnosis of and support for dementia) and (2) the Dementia Identification Scheme (DIS). The dataset included 7529 English general practices, of which 7142 were active throughout the 10‐year study period (April 2006 to March 2016). We controlled for a range of factors, including a contemporaneous hospital incentive scheme for dementia. Our dependent variable was the percentage of expected cases
(Edited publisher abstract)
Objective: In England, two primary care incentive schemes were introduced to increase dementia diagnosis rates to two‐thirds of expected levels. This study assesses the effectiveness of these schemes. Methods: The study used a difference‐in‐differences framework to analyse the individual and collective impacts of the incentive schemes: (1) Directed Enhanced Service 18 (DES18: facilitating timely diagnosis of and support for dementia) and (2) the Dementia Identification Scheme (DIS). The dataset included 7529 English general practices, of which 7142 were active throughout the 10‐year study period (April 2006 to March 2016). We controlled for a range of factors, including a contemporaneous hospital incentive scheme for dementia. Our dependent variable was the percentage of expected cases that was recorded on practice dementia registers (the “rate”). Results: From March 2013 to March 2016, the mean rate rose from 51.8% to 68.6%. Both DES18 and DIS had positive and significant effects. In practices participating in the DES18 scheme, the rate increased by 1.44 percentage points more than the rate for non‐participants; DIS had a larger effect, with an increase of 3.59 percentage points. These combined effects increased dementia registers nationally by an estimated 40 767 individuals. Had all practices fully participated in both schemes, the corresponding number would have been 48 685. Conclusion: The primary care incentive schemes appear to have been effective in closing the gap between recorded and expected prevalence of dementia, but the hospital scheme had no additional discernible effect. This study contributes additional evidence that financial incentives can motivate improved performance in primary care.
(Edited publisher abstract)
Subject terms:
primary care, diagnosis, payments, performance evaluation;
Journal of Mental Health, 25(4), 2016, pp.350-358.
Publisher:
Taylor and Francis
Place of publication:
London
Background: Research has found considerable variation in how far individuals with a diagnosis of mental illness experience discrimination.
Aims: This study tested four hypotheses: (i) a diagnosis of schizophrenia will be associated with more discrimination than depression, anxiety or bipolar disorder; (ii) people with a history of involuntary treatment will report more discrimination than people discrimination experiences.
Results: A multiple regression model found that study year, age, employment status, length of time in mental health services, disagreeing with the diagnosis, anticipating discrimination in personal relationships and feeling the need to conceal a diagnosis from others were significantly associated with higher levels of experienced discrimination.
Conclusion: Findings suggest that discrimination is not related to specific diagnoses but rather is associated with mental health problems generally. An association between unemployment and discrimination may indicate that employment protects against experiences of discrimination, supporting efforts to improve access to employment among people with a diagnosis of mental illness.
(Publisher abstract)
Background: Research has found considerable variation in how far individuals with a diagnosis of mental illness experience discrimination.
Aims: This study tested four hypotheses: (i) a diagnosis of schizophrenia will be associated with more discrimination than depression, anxiety or bipolar disorder; (ii) people with a history of involuntary treatment will report more discrimination than people without; (iii) higher levels of avoidance behaviour due to anticipated discrimination will be associated with higher levels of discrimination and (iv) longer time in contact with services will be associated with higher levels of discrimination.
Method: Three thousand five hundred and seventy-nine people using mental health services in England took part in structured telephone interviews about discrimination experiences.
Results: A multiple regression model found that study year, age, employment status, length of time in mental health services, disagreeing with the diagnosis, anticipating discrimination in personal relationships and feeling the need to conceal a diagnosis from others were significantly associated with higher levels of experienced discrimination.
Conclusion: Findings suggest that discrimination is not related to specific diagnoses but rather is associated with mental health problems generally. An association between unemployment and discrimination may indicate that employment protects against experiences of discrimination, supporting efforts to improve access to employment among people with a diagnosis of mental illness.
(Publisher abstract)
Subject terms:
mental health problems, diagnosis, discrimination, employment;